Olix Signs Option Contract for 300 Million KRW Ophthalmic Disease Treatment Program
[Asia Economy Reporter Eunmo Koo] Olix announced on the 7th that it has signed an option contract worth 274.2 million KRW for an ophthalmic disease treatment program with Thea Open Innovation. The contract amount represents 24% of last year's sales, and the contract period is until October 6, 2022.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Wallets Open Wide on Big News...300 Trillion Won Heads to the U.S., "Tax Breaks" Fail to Keep Funds at Home
- "Hope You Enjoy the 'Welfare' for Bereavement of Children"... Ridicule of Strike Non-Participants Intensifies Union Conflict at Samsung Electronics
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
